Literature DB >> 24305749

The effects of antenatal corticosteroids therapy on very preterm infants after chorioamnionitis.

Ken Miyazaki1, Madoka Furuhashi, Kaoru Ishikawa, Koji Tamakoshi, Tomoaki Ikeda, Satoshi Kusuda, Masanori Fujimura.   

Abstract

PURPOSE: To evaluate the effectiveness of antenatal corticosteroids (AC) therapy on outcomes of very low birthweight infants with histologic chorioamnionitis.
METHODS: We performed a retrospective analysis of 10,935 single infants born at a gestational age between 22 + 0 and 33 + 6 weeks and birth weight <1,500 g. Clinical data were obtained from the Neonatal Research Network that included the tertiary neonatal intensive care units throughout Japan between 2003 and 2008.
RESULTS: Data of 7,896 infants were available for the period 2003-2008 and were included in the analysis. According to logistic regression analysis, AC were significantly associated with reduced mortality [odds ratio (OR) = 0.50; p < 0.001], lower incidence of respiratory distress syndrome (OR = 0.72; p < 0.001), neonatal seizure (OR = 0.65; p = 0.003) and intraventricular hemorrhage (OR = 0.68; p = 0.001) in cases after histologic chorioamnionitis compared with the cases had no AC therapy (n = 3,271 vs. 4,625). Antenatal corticosteroids were significantly associated with reduced mortality [odds ratio (OR) = 0.60; p < 0.001] among the cases without histologic chorioamnionitis.
CONCLUSION: In the retrospective population-based study in Japan, AC exposure was significantly associated with a lower rate of death and neurological morbidity in cases with histologic chorioamnionitis. These outcome data in Japan will be important for further improvement of antenatal practice and care.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24305749     DOI: 10.1007/s00404-013-3106-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

Review 1.  Chorioamnionitis: implications for the neonate.

Authors:  Jessica E Ericson; Matthew M Laughon
Journal:  Clin Perinatol       Date:  2014-11-21       Impact factor: 3.430

Review 2.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

3.  Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis.

Authors:  Celeste Beck; Kelly Gallagher; Leigh A Taylor; Jeffery A Goldstein; Leena B Mithal; Alison D Gernand
Journal:  Obstet Gynecol       Date:  2021-06-01       Impact factor: 7.623

4.  Umbilical cord gene expression reveals the molecular architecture of the fetal inflammatory response in extremely preterm newborns.

Authors:  Daniel Costa; Robert Castelo
Journal:  Pediatr Res       Date:  2015-11-05       Impact factor: 3.756

5.  Histological chorioamnionitis, antenatal steroids, and neonatal outcomes in very low birth weight infants: A nationwide study.

Authors:  Hyun-Seung Lee; So Young Kim
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.